3Brihage C, Depresseux JC, Comar D. Radiation doimetry for bolus administration of H:150[J]. J NQD Med,1995,36:651-656.
4Ruotsulainen U, Sqhonen-Polvi H, Eronen E, et al. Estimated radiation dose to the newborn in GFDG-PET studies[J]. J Nud Med, 1996,37: 387-393.
5Delbeke D. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer lymphoma and melanoma[J]. J Nucl Med, 1999,40(4): 591.
6Miraldi F,Vesslle H,Faulhaber P F, et al. Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer[J]. Clin Nucl Med, 1998,23(1):3.
7R. Hustinx,P. Paulus,N. Jacquet,G. Jerusalem,T. Bury,P. Rigo. Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases[J] 1998,Annals of Oncology(4):397～401
8Delbeke D,Martin WH,Sandler MP,et al.Evaluation of benign vs malignant hepatic lesions with positron emission tomography[].Archives of Surgery.1998
9Okazumi S,Isono K,Enomoto K,et al.Evaluation of liver tumors using 18 Ffluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment[].The Journal of Nuclear Medicine.1992
10Torizuda,T,Tamaki N,Imokuma T,et al.Value of 18 F-FDG PET to monitor hepatocellular carcinoma after interventional therapy[].The Journal of Nuclear Medicine.1994
